B-type natriuretic Peptide: application in the community.
Natriuretic peptide assessment has represented a significant advance in the management of heart failure. In a syndrome in which clinical symptoms and signs can be either nonspecific or absent, the presence of a reliable biomarker to aid diagnosis, assess prognosis, and potentially guide treatment and aid in prevention of this syndrome has represented a significant advance. The following review will outline established and potential new roles for natriuretic peptide assessment in the community.
McDonald
Ken
K
St Vincent's University Hospital, Dublin, Ireland. kenneth.mcdonald@ucd.ie
Dahlström
Ulf
U
Aspromonte
Nadia
N
Jourdain
Patrick
P
Maisel
Alan
A
Mueller
Christian
C
Valle
Roberto
R
D006333:Heart Failure / Q000175:diagnosis* / Q000503:physiopathology; D006801:Humans; D008403:Mass Screening; D020097:Natriuretic Peptide, Brain; D011379:Prognosis; D018570:Risk Assessment; D012307:Risk Factors
D020097:Natriuretic Peptide, Brain